Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8+ T cells

J Infect Dis. 2015 Mar 1;211(5):821-6. doi: 10.1093/infdis/jiu541. Epub 2014 Oct 29.

Abstract

Growing evidence suggests a role for the immunomodulatory cytokine interleukin-10 (IL-10) in hepatitis C virus (HCV)-specific CD8(+) T-cell failure. To address the possible role of IL-10 during priming, we performed in vitro priming experiments with naive HCV-specific CD8(+) T cells and autologous monocyte-derived dendritic cells in the absence or presence of IL-10. Our results showed that IL-10, when present during priming, significantly reduced the frequency of HCV-specific CD8(+) T cells after coculture; It was directly targeting CD8(+) T cells and led to impaired effector cell differentiation. These results may provide a possible mechanistic basis for the association between early IL-10 elevation, T-cell failure, and viral persistence.

Keywords: CD8+ T cells; CD8+ T-cell responses; HCV; IL-10; chronic hepatitis C; chronic viral infection; dendritic cells; primary activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD8-Positive T-Lymphocytes / immunology*
  • Cells, Cultured
  • Coculture Techniques
  • Dendritic Cells / immunology*
  • Hepacivirus / immunology*
  • Humans
  • Interleukin-10 / immunology*

Substances

  • Interleukin-10